YDES

YD Bio Limited Ordinary Shares NASDAQ Listed Aug 29, 2025

Healthcare ·Biotechnology ·TW · ydesgroup.com

$5.06

-2.18% vs $5.17

Mkt Cap $358.3M

52w Low $4.62 2.2% of range 52w High $25.00

50d MA $6.20 200d MA $11.23

P/E (TTM) -9.0x

EV/EBITDA —

P/B 3.2x

Debt/Equity 0.0x

ROE —

P/FCF -4.4x

RSI (14) —

ATR (14) —

Beta 0.22

50d MA $6.20

200d MA $11.23

Avg Volume 17.6K

Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

SIC Code

8071

CIK (SEC)

2011674

Phone

+82 2 546 1611

No. 3, Xingnan St. · Taipei, TX 115001 · TW

Institutional (13F) — Top 7 All ↗

#	Manager	Shares	Value	Chg	Period
1	Cypress Capital Management Llc (Wy)	30,690	$236K	Added	Mar 2026
2	Citadel Advisors Llc	19,450	$150K	Added	Mar 2026
3	Ubs Group Ag	11,628	$90K	Added	Mar 2026
4	Wolverine Asset Management Llc	4,886	$38K	Added	Mar 2026
5	Citigroup Inc	1,709	$21K	New	Dec 2025
6	Morgan Stanley	299	$4K	Reduced	Dec 2025
7	Fmr Llc	1	$8	—	Mar 2026

Mutual Funds / ETFs (N-PORT) — Top 0 All ↗

No N-PORT holders found.

Data updated apr 24, 2026 11:46am · Source: massive.com